Severe combined hyperlipidaemia and retinal lipid infiltration in a patient with Type 2 diabetes mellitus

Lipids in Health and Disease

Volumn 5, Issue , 2006, Pages

  Davey, Rachel A ^a   Tebbutt, Niall C ^a   Favaloro, Jenny M ^a   O'Neal, David N ^a   Rae, Derek ^b   Zajac, Jeffrey D ^a   Best, James D ^a  

^a UNIVERSITY OF MELBOURNE   (Australia)

^b ST VINCENT S HOSPITAL   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

APOLIPOPROTEIN E; CHOLESTEROL ESTER; GEMFIBROZIL; GLICLAZIDE; INTERMEDIATE DENSITY LIPOPROTEIN; LIPOPROTEIN;

ADULT; ALLELE; ANAMNESIS; ARTICLE; BLINDNESS; CASE REPORT; CLINICAL EXAMINATION; DIET THERAPY; DISEASE ASSOCIATION; DISEASE SEVERITY; ELECTROPHORESIS; FAMILIAL DISEASE; FEMALE; GENE SEQUENCE; HISTOPATHOLOGY; HOMOZYGOSITY; HUMAN; HYPERLIPIDEMIA; HYPERLIPOPROTEINEMIA TYPE 3; LABORATORY TEST; NON INSULIN DEPENDENT DIABETES MELLITUS; RETINA DISEASE; RETINAL LIPID INFILTRATION; VISUAL ACUITY; VISUAL SYSTEM EXAMINATION;

AGED; DIABETES MELLITUS, TYPE 2; FEMALE; HEMORRHAGE; HUMANS; HYPERLIPIDEMIAS; LIPID METABOLISM; LIPIDS; RETINA;

EID: 33846608241     PISSN: None     EISSN: 1476511X     Source Type: Journal    
DOI: 10.1186/1476-511X-5-29     Document Type: Article

References (12)

1. Matsunaga A, Sasaki J, Komatsu T, Kanatsu K, Tsuji E, Moriyama K, Koga T, Arakawa K, Oikawa S, Saito T, et al.: A novel apolipoprotein E mutation, E2 (Arg25Cys), in lipoprotein glomerulopathy. Kidney Int 1999, 56(2):421-427.
2. Warnick GR, Mayfield C, Albers JJ, Hazzard WR: Gel isoelectric focusing method for specific diagnosis of familial hyperlipoproteinemia type 3. Clin Chem 1979, 25(2):279-284.
3. Hixson JE, Vernier DT: Restriction isotyping of human apolipoprotein E by gene amplification and cleavage with Hhal. J Lipid Res 1990, 31(3):545-548.
4. Paik YK, Chang DJ, Reardon CA, Davies GE, Mahley RW, Taylor JM: Nucleotide sequence and structure of the human apolipoprotein E gene. Proc Natl Acad Sci USA 1985, 82(10):3445-3449.
5. Balson KR, Niall JF, Best JD: Glomerular lipid depostition and proteinuria in a patient with familial dysbetalipoproteinaemia. J Intern Med 1996, 240(3):157-159.
6. Fredrickson DS, Morganroth J, Levy RI: Type III hyperlipoproteinemia: an analysis of two contemporary definitions. Ann Intern Med 1975, 82(2):150-157.
7. Hazzard WR, Porte D Jr, Bierman EL: Abnormal lipid composition of very low density lipoproteins in diagnosis of broad-beta disease (type 3 hyperlipoproteinemia). Metabolism 1972, 21(11):1009-1019.
8. Eto M, Watanabe K, Sato T, Makino I: Apolipoprotein-E2 and hyperlipoproteinemia in noninsulin-dependent diabetes mellitus. J Clin Endocrinol Metab 1989, 69(6):1207-1212.
9. Suzaki K, Kobori S, Ueno S, Uehara M, Kayashima T, Takeda H, Fukuda S, Takahashi K, Nakamura N, Uzawa H, et al.: Effects of plasmapheresis on familial type III hyperlipoproteinemia associated with glomerular lipidosis, nephrotic syndrome and diabetes mellitus. Atherosclerosis 1990, 80(3):181-189.
10. Cusick M, Chew EY, Chan CC, Kruth HS, Murphy RP, Ferris FL 3rd: Histopathology and regression of retinal hard exudates in diabetic retinopathy after reduction of elevated serum lipid levels. Ophthalmology 2003, 110(11):2126-2133.
11. Li CM, Chung BH, Presley JB, Malek G, Zhang X, Dashti N, Li L, Chen J, Bradley K, Kruth HS, et al.: Lipoprotein-like particles and cholesteryl esters in human Bruch's membrane: initial characterization. Invest Ophthalmol Vis Sci 2005, 46(7):2576-2586.
12. Espinosa-Heidmann DG, Sall J, Hernandez EP, Cousins SW: Basal laminar deposit formation in APO B100 transgenic mice: complex interactions between dietary fat, blue light, and vitamin E. Invest Ophthalmol Vis Sci 2004, 45(1):260-266.